久光製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/01/10 | 4,250 | 4,685 | 4,244 | 4,656 | +612 | +15.1% | 2,090,100 |
| 2025/01/09 | 4,044 | 4,047 | 4,017 | 4,044 | -7 | -0.2% | 130,900 |
| 2025/01/08 | 4,071 | 4,091 | 4,030 | 4,051 | -16 | -0.4% | 86,400 |
| 2025/01/07 | 4,044 | 4,090 | 4,039 | 4,067 | +24 | +0.6% | 102,800 |
| 2025/01/06 | 4,085 | 4,085 | 4,043 | 4,043 | -42 | -1% | 98,900 |
| 2024/12/30 | 4,155 | 4,160 | 4,077 | 4,085 | -55 | -1.3% | 77,700 |
| 2024/12/27 | 4,125 | 4,152 | 4,115 | 4,140 | +49 | +1.2% | 83,000 |
| 2024/12/26 | 4,066 | 4,116 | 4,066 | 4,091 | +26 | +0.6% | 94,400 |
| 2024/12/25 | 4,085 | 4,086 | 4,025 | 4,065 | -15 | -0.4% | 96,000 |
| 2024/12/24 | 4,075 | 4,092 | 4,045 | 4,080 | -20 | -0.5% | 142,300 |
| 2024/12/23 | 4,079 | 4,133 | 4,077 | 4,100 | -19 | -0.5% | 83,200 |
| 2024/12/20 | 4,138 | 4,151 | 4,092 | 4,119 | +38 | +0.9% | 177,300 |
| 2024/12/19 | 4,072 | 4,118 | 4,069 | 4,081 | -30 | -0.7% | 111,300 |
| 2024/12/18 | 4,157 | 4,157 | 4,111 | 4,111 | -39 | -0.9% | 91,900 |
| 2024/12/17 | 4,210 | 4,227 | 4,150 | 4,150 | -65 | -1.5% | 97,200 |
| 2024/12/16 | 4,235 | 4,248 | 4,188 | 4,215 | -51 | -1.2% | 90,400 |
| 2024/12/13 | 4,225 | 4,284 | 4,224 | 4,266 | -17 | -0.4% | 106,600 |
| 2024/12/12 | 4,298 | 4,300 | 4,248 | 4,283 | +18 | +0.4% | 140,900 |
| 2024/12/11 | 4,250 | 4,299 | 4,242 | 4,265 | +49 | +1.2% | 111,500 |
| 2024/12/10 | 4,238 | 4,256 | 4,198 | 4,216 | +6 | +0.1% | 117,100 |
| 2024/12/09 | 4,240 | 4,255 | 4,209 | 4,210 | -30 | -0.7% | 91,400 |
| 2024/12/06 | 4,245 | 4,271 | 4,221 | 4,240 | -10 | -0.2% | 60,200 |
| 2024/12/05 | 4,238 | 4,264 | 4,215 | 4,250 | +12 | +0.3% | 97,300 |
| 2024/12/04 | 4,239 | 4,251 | 4,191 | 4,238 | -29 | -0.7% | 111,700 |
| 2024/12/03 | 4,293 | 4,301 | 4,243 | 4,267 | +33 | +0.8% | 115,400 |
| 2024/12/02 | 4,160 | 4,256 | 4,131 | 4,234 | +9 | +0.2% | 103,600 |
| 2024/11/29 | 4,277 | 4,277 | 4,225 | 4,225 | -52 | -1.2% | 73,500 |
| 2024/11/28 | 4,269 | 4,288 | 4,246 | 4,277 | +33 | +0.8% | 55,300 |
| 2024/11/27 | 4,256 | 4,269 | 4,232 | 4,244 | -4 | -0.1% | 64,900 |
| 2024/11/26 | 4,272 | 4,302 | 4,222 | 4,248 | -32 | -0.7% | 94,400 |
| 2024/11/25 | 4,300 | 4,318 | 4,272 | 4,280 | +3 | +0.1% | 87,400 |
| 2024/11/22 | 4,322 | 4,328 | 4,239 | 4,277 | -7 | -0.2% | 91,700 |
| 2024/11/21 | 4,245 | 4,297 | 4,233 | 4,284 | +50 | +1.2% | 100,400 |
| 2024/11/20 | 4,268 | 4,288 | 4,225 | 4,234 | -20 | -0.5% | 82,400 |
| 2024/11/19 | 4,237 | 4,269 | 4,230 | 4,254 | +30 | +0.7% | 63,200 |
| 2024/11/18 | 4,210 | 4,228 | 4,188 | 4,224 | +4 | +0.1% | 77,600 |
| 2024/11/15 | 4,284 | 4,284 | 4,215 | 4,220 | -19 | -0.4% | 74,800 |
| 2024/11/14 | 4,283 | 4,288 | 4,239 | 4,239 | -56 | -1.3% | 83,500 |
| 2024/11/13 | 4,350 | 4,357 | 4,284 | 4,295 | -73 | -1.7% | 97,600 |
| 2024/11/12 | 4,399 | 4,399 | 4,321 | 4,368 | -7 | -0.2% | 110,500 |
| 2024/11/11 | 4,388 | 4,428 | 4,351 | 4,375 | +2 | ±0% | 145,000 |
| 2024/11/08 | 4,450 | 4,464 | 4,347 | 4,373 | -87 | -2% | 141,800 |
| 2024/11/07 | 4,440 | 4,483 | 4,437 | 4,460 | +22 | +0.5% | 98,700 |
| 2024/11/06 | 4,475 | 4,496 | 4,418 | 4,438 | -37 | -0.8% | 136,600 |
| 2024/11/05 | 4,464 | 4,507 | 4,444 | 4,475 | -5 | -0.1% | 178,500 |
| 2024/11/01 | 4,418 | 4,525 | 4,390 | 4,480 | -8 | -0.2% | 164,100 |
| 2024/10/31 | 4,430 | 4,500 | 4,430 | 4,488 | +84 | +1.9% | 238,700 |
| 2024/10/30 | 4,393 | 4,433 | 4,388 | 4,404 | +39 | +0.9% | 183,000 |
| 2024/10/29 | 4,338 | 4,399 | 4,311 | 4,365 | +27 | +0.6% | 141,500 |
| 2024/10/28 | 4,311 | 4,354 | 4,277 | 4,338 | +55 | +1.3% | 154,700 |
151～
200
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 久光薬 | 428,400円 | +5.8% | +1.2% | 2.80% | 13.87倍 | 1.10倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| 住友ファーマ | 140,700円 | -11.0% | +206.6% | 0.00% | 13.97倍 | 3.30倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| 参天薬 | 156,700円 | -2.0% | -7.3% | 2.43% | 15.32倍 | 1.82倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| ツムラ | 361,300円 | +3.8% | -19.9% | 3.76% | 11.74倍 | 0.90倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 322,200円 | +3.6% | -15.3% | 3.85% | 9.05倍 | 0.88倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム
